Full Text View
Tabular View
No Study Results Posted
Related Studies
Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients
Expanded access is currently available for this treatment.
Study NCT00633373   Information provided by APT Pharmaceuticals, Inc.
First Received: March 5, 2008   Last Updated: October 14, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lung Transplant
Interventions listed in this trial
Cyclosporine Inhalation Solution
Additional drug interventions recognized in this trial
Cyclosporine
Cyclosporins
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
APT Pharmaceuticals, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services